Irish firm claims breakthrough in pre-diabetes treatment

An Irish company is claiming a major breakthrough in the treatment of Type-2 diabetes.

Irish firm claims breakthrough in pre-diabetes treatment
Fri, 28 Oct, 2016 - 07:44

An Irish company is claiming a major breakthrough in the treatment of Type-2 diabetes.

Dublin-based Nuritas has uncovered a body acid which can balance blood sugar levels in humans.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

Benefit image

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

DAA denies ad campaign about airport emissions was effort at greenwashing  DAA denies ad campaign about airport emissions was effort at greenwashing 
ieBusiness Podcast: Cork Film Festival Director Fiona Clark speaks of soaring running costs ieBusiness Podcast: Cork Film Festival Director Fiona Clark speaks of soaring running costs
Jaguar Land Rover cyber attack Jaguar Land Rover cyber attack cost UK €2.2bn
CourtsHeathrowdiabetesNuritasHealth
<p>Residents inspect houses damaged during a flood in Malalak, West Sumatra, Indonesia, last November. Picture: Ade Yuandha/AP</p>

Our money is fuelling climate change

READ NOW

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Latest

Business

Push Notifications

By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.

Sign Up
IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Fergus Finlay
Fergus Finlay

Analysis

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited